Biomarkers is a peer‑reviewed academic journal that publishes original research articles, reviews, and short communications on the discovery, validation, and application of biomarkers in biochemistry, molecular biology, and related biomedical fields. The journal emphasizes studies that advance the understanding of biomarkers for disease diagnosis, prognosis, therapeutic monitoring, and risk assessment.
Publication details
- Discipline: Biochemistry, molecular diagnostics, and related biomedical sciences
- Publisher: Taylor & Francis
- Publication history: 1996 – present
- Frequency: Eight issues per year (approximately monthly, with combined issues)
- Language: English
- Editor‑in‑Chief: Martin Möckel (Charité – Universitätsmedizin Berlin)
Identifiers
- Print ISSN: 1354‑750X
- Electronic ISSN: 1366‑5804
- CODEN: BIOMFA
- LCCN: 96641474
- OCLC: 34726943
Abstracting and indexing
The journal is indexed in major bibliographic databases, including Scopus, Web of Science, and the National Library of Medicine’s NLM Catalog. Its articles are also catalogued in JSTOR and other academic repositories.
Impact factor
According to the Journal Citation Reports (2015), Biomarkers had an impact factor of 2.016. (More recent impact metrics may be available from updated reports.)
Scope and content
Biomarkers covers a wide range of topics such as:
- Molecular and cellular biomarkers for disease detection and monitoring
- Proteomic, genomic, metabolomic, and imaging biomarkers
- Clinical validation studies and regulatory considerations
- Novel assay development and analytical validation
- Translational research linking biomarker discovery to clinical practice
Online access
Current issues and an archival collection of past issues are available through the journal’s website hosted by Taylor & Francis.
References
- “Biomarkers.” Journal Citation Reports, 2015, Web of Science (Science ed.), Clarivate Analytics.
This entry is based on information from the journal’s Wikipedia page and publicly available publisher data.